Current Firm
Digitalis Ventures
Focus
Biotech, Digital Health
Samuel Bjork is a Partner at Digitalis Ventures, a venture capital firm focused on identifying and supporting transformative companies at the intersection of technology and life sciences. With expertise spanning biotech, digital health, artificial intelligence, and deeptech, Bjork invests in innovative founders and technologies poised to reshape industries and improve human outcomes. At Digitalis Ventures, he leverages his investment acumen to identify promising early-stage opportunities and provide strategic guidance to portfolio companies navigating complex technical and market challenges. Bjork's multidisciplinary focus reflects a commitment to backing bold innovation across sectors where cutting-edge technology meets meaningful real-world application. Through his work, he connects with entrepreneurs, engineers, and scientists developing the next generation of breakthrough solutions in healthcare, computing, and advanced technologies.
Samuel Bjork is a Partner, Digitalis Ventures at Digitalis Ventures, based in Boston, MA.
Samuel's investment focus spans Biotech, Digital Health, AI, Deeptech, primarily investing at the Pre-Seed, Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Samuel Bjork is a Partner, Digitalis Ventures at Digitalis Ventures, based in Boston, MA. Their investment focus includes Biotech, Digital Health, AI.
Samuel Bjork focuses on investments in Biotech, Digital Health, AI, Deeptech through Digitalis Ventures. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Samuel Bjork is currently at Digitalis Ventures, headquartered in Boston, MA, serving as Partner, Digitalis Ventures.